Trade Summary

4 days ago, DeSimone Jill, serving as Dir at Praxis Precision Medicines, Inc. (PRAX), sold 11,600 shares at $311.32 per share, for a total transaction value of $3,611,334.88. Following this transaction, DeSimone Jill now holds 2,337 shares of PRAX.

This sale represents a 83.23% decrease in DeSimone Jill's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, June 24, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 26, 2026 at 5:09 PM ET, 2 days after the trade was made.

Praxis Precision Medicines, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.